Subscribe: Market Wire - Pharmaceuticals and Biotech: Biotech
http://img.marketwire.com/rss/mwPBBI.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
announced  aug  august  cannabis  company  development  marketwired aug  marketwired august  marketwired  today announced  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Pharmaceuticals and Biotech: Biotech

Marketwired - Biotech



Marketwired - Biotech



Last Build Date: Tue, 22 Aug 2017 10:32:28 EDT

Copyright: Copyright: (C) Marketwired
 



BioElectronics' President Discusses Company's Many Opportunities

Tue, 22 Aug 2017 10:00:00 EDT

FREDERICK, MD--(Marketwired - Aug 22, 2017) - The following is a statement from BioElectronics (OTC PINK: BIEL).




Player's Network, Inc. Releases a Video Tour of its Subsidiary Green Leaf Farms Called "A Glimpse Into Green Leaf" Capturing an Inside look of their State-of-the-Art Cultivation and Production Facility

Tue, 22 Aug 2017 09:13:31 EDT

This is a short documentary showcasing Phase One development of its facility, an introduction to its operational team and provides insight into its strategy to compete in the Nevada marketplace




State of Mexico Begins Purchasing Medical Marijuana Inc.'s Products for its Citizens -- CFN Media

Tue, 22 Aug 2017 09:00:00 EDT

SEATTLE, WA--(Marketwired - Aug 22, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Medical Marijuana Inc.'s (OTC PINK: MJNA) opportunity in Mexico now that the State of Mexico is buying the company's HempMeds® RSHO-X cannabidiol (CBD) oil for its citizens.




GeoVax to Present at Upcoming Immuno-Oncology Conference

Tue, 22 Aug 2017 09:00:00 EDT

Presentation to Include Preliminary Data from GeoVax's Cancer Vaccine Program




OncBioMune Submits Documents Necessary to Commercialize Norepinefrine for Low Blood Pressure and Heart Failure in Mexico

Tue, 22 Aug 2017 08:45:12 EDT

BATON ROUGE, LA--(Marketwired - August 22, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of targeted cancer therapies, a proprietary cancer vaccine technology and commercialization of a portfolio of products internationally, today reports that the requisite documents for transferring the Mexican rights to market Norepinefrine across the country to OncBioMune have been submitted to the Mexican Ministry of Health. On June 19, 2017, the Company announced acquiring the sanitary registration and intellectual property rights to Norepinefrine in Mexico and other markets from the Mexican subsidiary of the world's biggest generic drug company.




VPR Brands, LP announces Second Quarter 2017 Results

Tue, 22 Aug 2017 08:30:00 EDT

FORT LAUDERDALE, FL--(Marketwired - Aug 22, 2017) - VPR Brands, LP (OTC PINK: VPRB), a market leader specializing in vaporizers and accessories for essential oils, cannabis concentrates and extracts, as well as electronic cigarettes containing nicotine, has released its second quarter 2017 results of operations. Revenues for the second quarter 2017 totaled $1,036,806, representing an increase of 31.82% over $786,535 for the first quarter 2017 and an increase of 1,685% over $61,526 for the second quarter 2016. VPR Brands posted a gross profit of $411,397 for the second quarter 2017, which represents a 49.59% increase over the $275,014 gross profit for the first quarter 2017, and a 1,673% increase of the second quarter 2016 gross profit. For the second quarter 2017, VPR Brands had a gross margin of 39.68%, representing an increase over the first quarter 2017 gross margin of 34.96% and a decrease from the second quarter 2016 gross margin of 39.96%.




Black Stallion Corporate Update

Tue, 22 Aug 2017 08:30:00 EDT

BUFFALO, NY--(Marketwired - Aug 22, 2017) - Black Stallion (OTC PINK: BLKG) is pleased to announce that it is preparing to implement its corporate strategies through various ?platforms. With the recently announced execution of the Licensing Agreement between Active Lab International, Inc. ("Active Lab") and Black Stallion, the Company has now established an online retailer that will provide the launch pad for the next phase of Black Stallion's multi-platform expansion. The platform that will be the driving force behind this expansion is the inclusion of "Alt-Currencies," or better known as, "Cryptocurrency." This will include the popular currencies such as Bitcoin and Ethereum. 




BioElectronics Engages Keith Nalepka As Vice President of Sales and Marketing

Tue, 22 Aug 2017 08:30:00 EDT

FREDERICK, MD--(Marketwired - Aug 22, 2017) -  BioElectronics Corporation (OTC PINK: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has engaged Keith Nalepka as the Vice President of Sales and Marketing. 




InspireMD Shares CGuard(TM) EPS Video Testimonials from European Key Opinion Leaders

Tue, 22 Aug 2017 08:05:00 EDT

TEL AVIV, ISRAEL--(Marketwired - Aug 22, 2017) - InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR) (NYSE American: NSPR.WS) (NYSE MKT: NSPR.WS) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it has posted video testimonials about its CGuardT Embolic Prevention System from several European key opinion leaders on its website: http://www.inspiremd.com/en/kol-testimonials/




VIVUS to Present at 2017 Wells Fargo Healthcare Conference on September 7, 2017

Tue, 22 Aug 2017 08:00:00 EDT

CAMPBELL, CA--(Marketwired - August 22, 2017) - VIVUS,Inc. (NASDAQ: VVUS) (the "Company"), a biopharmaceutical company committed to the development and commercialization of innovative therapies focusing on treatments for patients with serious unmet medical needs, today announced that Seth H. Z. Fischer, Chief Executive Officer, will present at the 2017 Wells Fargo Healthcare Conference on Thursday, September 7, 2017 at 2:15 pm ET in Boston. During this presentation, Mr. Fischer will give a corporate overview, review the Company's clinical and commercial product portfolio, and discuss recent efforts to obtain additional product candidates.




InspireMD Announces Notification of NYSE AMERICAN Listing Deficiency and Expectation to Regain Compliance

Tue, 22 Aug 2017 08:00:00 EDT

TEL AVIV, ISRAEL--(Marketwired - Aug 22, 2017) - InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it received a letter from the NYSE American on August 17, 2017 indicating that InspireMD does not meet a certain NYSE American LLC (the "NYSE American") continued listing standard as set forth in Part 10, Section 1003(a)(iii) of the Company Guide of the NYSE American, due to the fact the Company had reported stockholders' equity of less than $6 million as of June 30, 2017 and had net losses in its five most recent fiscal years ended December 31, 2016. The Exchange's notice has no immediate effect on the listing of the Company's common stock on the Exchange. The Company's management is reviewing its options to address the deficiency and expects to submit a compliance plan to the NYSE American on or before September 17, 2017, the deadline set by the Exchange, addressing how it intends to regain compliance with Sections 1003(a)(iii) of the Company Guide by February 17, 2019.




Helix Announces Peer-Review Publication of V-DOS47 in Frontiers in Immunology Journal

Tue, 22 Aug 2017 07:30:00 EDT

Article Title: Development and Characterization of a Camelid Single Domain Antibody-Urease Conjugate That Targets Vascular Endothelial Growth Factor Receptor 2




Moleculin Announces Meeting with European Medicines Agency

Tue, 22 Aug 2017 07:30:00 EDT

HOUSTON, TX--(Marketwired - August 22, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today announced it will meet with the European Medicines Agency (EMA) on Wednesday, August 30, 2017 to discuss Clinical Trial Authorization for the study of Annamycin for the treatment of acute myeloid leukemia.




Revive Therapeutics Appoints Dr. Arun Sanyal, MD, as Scientific Advisor for Cannabinoid-Based Therapeutics Targeting Liver Diseases

Tue, 22 Aug 2017 07:00:00 EDT

TORONTO, ONTARIO--(Marketwired - Aug. 22, 2017) - Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on the research, development and commercialization of novel treatments for serious and unmet medical needs, today announced that Dr. Arun Sanyal, M.D., will join the Company as a Scientific Advisor for cannabinoid-based therapeutics targeting liver diseases.




Advantis Corp. Setting Up Multi-State Amster-Can Canning Solutions

Mon, 21 Aug 2017 09:15:00 EDT

NEWPORT BEACH, CA--(Marketwired - Aug 21, 2017) - ADVANTIS CORPORATION (OTC PINK: ADVT) is finalizing agreements with client partners in Oregon and Las Vegas, Nevada to package their goods in with Amster-Can.




VistaGen Therapeutics Expands VistaStem's Scientific Advisory Board with Appointment of Medicinal Chemistry Expert, David Rotella, PhD

Mon, 21 Aug 2017 09:00:00 EDT

SOUTH SAN FRANCISCO, CA--(Marketwired - August 21, 2017) - VistaGen Therapeutics Inc. (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing new generation medicines for depression and other central nervous system (CNS) disorders, today announced the appointment of David Rotella, PhD, to the Scientific Advisory Board of VistaStem Therapeutics, the Company's wholly owned subsidiary focused on using its stem cell technology for small molecule drug rescue and regenerative medicine. Dr. Rotella joins Gordon Keller, PhD, Director of the McEwen Centre for Regenerative Medicine in Toronto, James Sanders, PhD, retired Senior Director and Preclinical Development Leader at Johnson & Johnson, and Ron Wester, PhD, retired Vice President, Medicinal Chemistry and Drug Discovery at Pfizer Global R&D, on VistaStem's Scientific Advisory Board.




Medovex Corporation Appoints Gorlin Companies Managing Partner Jesse Crowne Director and Executive Co-Chairman of the Board

Mon, 21 Aug 2017 09:00:00 EDT

ATLANTA, GA--(Marketwired - Aug 21, 2017) - Medovex Corp. (NASDAQ: MDVX) ("Medovex" or the "Company"), the developer of the DenerveXT System, a new and novel device designed for enduring relief of Facet Joint Syndrome related to back pain, today announced it has appointed Jesse Crowne as Director and Executive Co-Chairman of the Board.




biOasis Appoints Doug Williams, MBA, Executive Vice President, Chief Business Officer

Mon, 21 Aug 2017 08:00:00 EDT

Williams brings significant experience in working with both large, multinational pharmaceutical companies & start-up biotechnology alliances




The Alliance for Regenerative Medicine Releases Q2 2017 Data Report, Highlighting Sector Trends and Metrics

Fri, 18 Aug 2017 11:01:25 EDT

WASHINGTON, DC--(Marketwired - Aug 18, 2017) - The Alliance for Regenerative Medicine (ARM) released today its most recent quarterly data report, offering an in-depth look at cell therapy, gene therapy, tissue engineering and broader global regenerative medicine sector trends and metrics in the second quarter and first half of 2017.




Ritter Pharmaceuticals Announces Phase 3 Plans after its End of Phase 2 Meeting with FDA on RP-G28 for Lactose Intolerance

Fri, 18 Aug 2017 09:30:00 EDT

Company has incorporated guidance from FDA on key elements of its Phase 3 program to support a New Drug Application (NDA) for RP-G28




Ceapro Reports 2017 Second Quarter Business Update and Financial Results

Fri, 18 Aug 2017 09:05:00 EDT

Continued advancement for expansion into nutraceutical market

Results from animal studies evaluating bioavailability of impregnated CoQ10 with beta glucan expected Q4 2017

Encouraging preliminary data from bio-efficacy study evaluating avenanthramides in exercise-induced inflammation warrant extension to evaluate additional biomarkers




Streetwise Reports Examines One Regenerative Medicine Firm to 'Keep a Close Eye On'

Fri, 18 Aug 2017 08:45:00 EDT

SAN FRANCISCO, CA--(Marketwired - August 18, 2017) - In an update on this company's clinical cell therapy programs targeting blood cancers and osteoarthritis in the knee, Gabrielle Zhou of Maxim Group describes progress that sets the stage for "value inflection."




Dewmar International BMC, Inc. (DEWM) Partners with Arkansas Company to Apply for Marijuana Cultivation and Dispensary Licenses

Fri, 18 Aug 2017 08:43:24 EDT

HOUSTON, TX--(Marketwired - Aug 18, 2017) - Dewmar International BMC, Inc. (the "Company") (OTC PINK: DEWM) today announced that it has partnered with a long-standing Arkansas company in a joint effort to see a cannabis cultivation and dispensary permit to be issued during fourth quarter 2017.




ViaDerma, Inc. Set to Begin Sales of its FDA Registered Topical Antibiotic in September with Initial Orders from Japan

Fri, 18 Aug 2017 08:00:00 EDT

Viaderma, Inc. announces Galaxy Solutions, Inc. as new sales representative for select Asia Pacific markets




HempAmericana selected as featured Investment for new Crowd Funding Portal, Minivest

Fri, 18 Aug 2017 08:00:00 EDT

NEW YORK, NY--(Marketwired - Aug 18, 2017) - HempAmericana, Inc. (OTC: HMPQ) -- HempAmericana Inc. is excited to announce that the Company has been selected to be the first investment offered on a new and exciting Crowd Funding site designed exclusively for qualified Reg A offerings. 




The Role of Clinical Endpoint Committees in Medical Device Trials, a New Webinar Presented by Premier Research and Hosted by Xtalks

Fri, 18 Aug 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - August 18, 2017) - This webinar will discuss the value of clinical endpoint committees in medical device evaluation programs and explore the process of organizing, managing, and implementing a centralized adjudication process for standardizing study endpoints. The live broadcast takes place on Tuesday, September 12, 2017, with keynote speakers from Premier Research Joanne Emmett, Vice President of Medical Device & Diagnostics, and Janet Kube, Directorof Project Management.




Vivakor Launches Exploration Division to Acquire Interest in Producing Wells

Thu, 17 Aug 2017 13:28:30 EDT

LAS VEGAS, NV--(Marketwired - August 17, 2017) - Vivakor Inc. (OTC PINK: VIVK) announces that the company has created a division for developing and acquiring fractional ownership interest in producing oil wells within the United States. VivaVentures Exploration will acquire working interest in near term operating wells focused in certain areas of the Western States to start and then expand such acquisitions as management deems advantageous. Such fractional ownership will extend across multiple wells enabling diversification of the investment. Additionally, the VivaVentures Exploration division will be procuring shallow wells that other Vivakor technologies may be applied to increase well productivity significantly.




Breaking News: CBIS/FSAO NAC Harvest Planning Session Held Yesterday Has Accelerated the Completion of the 60-acre Industrial Hemp Project Planted on the 250 acre CBIS/FSO NAC MBS001 Plot Currently Under Harvest

Thu, 17 Aug 2017 13:07:26 EDT

IRVINE, CA--(Marketwired - Aug 17, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and Free Spirit Organics Native American Corporation (FSO NAC) is pleased to announce that after yesterday's planning session the group has accelerated the completion of the 60-acre project planted on the 250-acre CBIS/FSO NAC MBS001 plot currently underway. 




Medovex Corporation Names Charlie Farrahar Chief Financial Officer

Thu, 17 Aug 2017 12:50:00 EDT

ATLANTA, GA--(Marketwired - Aug 17, 2017) - Medovex Corp. (NASDAQ: MDVX) ("Medovex" or the "Company"), the developer of the DenerveXT System, a new and novel device designed for enduring relief of Facet Joint Syndrome related to back pain, today reported it has named Charlie Farrahar as its Chief Financial Officer.




HealthDatix initiates pilot program with West Florida Health Network

Thu, 17 Aug 2017 11:48:19 EDT

SMITHTOWN, NY--(Marketwired - Aug 17, 2017) -  iGambit Inc. (OTCQB: IGMB) is pleased to announce that the company's wholly owned subsidiary, HealthDatix, Inc. has entered into a pilot program with West Florida Health Network (WFHN), which is a Community Integrated Network (CIN).




Innovation and robotics will speed up tumour analysis

Thu, 17 Aug 2017 11:30:00 EDT

VANCOUVER, BC--(Marketwired - August 17, 2017) - Genome BC is investing in a cancer research project that aims to speed up genetic tests of tumours through the development of a robotics system.




HCi Viocare Targets the Global Diabetes Market by Shipping the 1st Smart Diabetic Walker Boot

Thu, 17 Aug 2017 09:26:28 EDT

GLASGOW, SCOTLAND--(Marketwired - Aug 17, 2017) - HCi Viocare (OTCQB: VICA) is pleased to announce that it has shipped the world's 1st Smart Diabetic Walker Boot, equipped with the company's patent pending Flexisense technology, to a global diabetes-market leading manufacturer.




EnWave Corporation Hires Adelaide Capital Markets to Provide Investor Relations Services

Thu, 17 Aug 2017 09:00:00 EDT

VANCOUVER, BC--(Marketwired - August 17, 2017) - EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company") today announced that it has hired Adelaide Capital Markets ("ACM") to provide investor relations and corporate development services for the Company.




Neptune annonce l'élection de ses administrateurs

Thu, 17 Aug 2017 08:00:00 EDT

LAVAL, QUÉBEC--(Marketwired - 17 août 2017) - Neptune Technologies & Bioressources inc. (« Neptune » ou la « Société ») (NASDAQ:NEPT)(TSX:NEPT) annonce que les candidats désignés dans la circulaire de sollicitation de procurations datée du 13 juillet 2017 ont été élus à titre d'administrateurs de la Société. Les résultats détaillés du vote pour l'élection des administrateurs à l'assemblée annuelle des actionnaires tenue à Montréal le 15 août 2017 sont présentés ci-dessous.




Neptune Announces the Election of its Directors

Thu, 17 Aug 2017 08:00:00 EDT

LAVAL, QUEBEC--(Marketwired - Aug. 17, 2017) - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (NASDAQ:NEPT)(TSX:NEPT) announces that the nominees listed in its management proxy circular dated July 13, 2017 were elected as directors of the Corporation. The detailed results of the vote for the election of directors at its Annual Meeting of Shareholders held on August 15, 2017 in Montreal are set out below.




Golden Leaf Holdings to Hold Conference Call to Review Second Quarter 2017 Results

Thu, 17 Aug 2017 08:00:00 EDT

TORONTO, ON--(Marketwired - August 17, 2017) - Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE: GLH) (CSE: GLH.CN) (CNSX: GLH) (OTCQB: GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced that it will report its financial results for the quarter ended June 30, 2017 on Tuesday, August 29, 2017, after market-close. Golden Leaf's management, led by Mr. William Simpson, Chief Executive Officer, will also hold a conference call to review the results at 4:30 PM ET on Tuesday, August 29, 2017.




Patients Are Not the #1 Target for Social Media & Other Digital Marketing Strategies, New Study Finds

Wed, 16 Aug 2017 17:42:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - August 16, 2017) - A new study of pharmaceutical marketing teams found that the primary digital strategy priority is to educate and communicate with physicians, making communication with patients across digital platforms a secondary priority.




Genome BC: Cannabis traits unlocked for better regulation

Wed, 16 Aug 2017 15:29:33 EDT

VANCOUVER, BC--(Marketwired - August 16, 2017) - Medical cannabis production is one of the fastest growing agri-biotech industries in BC, a province which is home to over 20% of Canada's licensed producers of medical cannabis. The federal Cannabis Act, which is currently before parliament, will legalize the non-medical use of cannabis and further expand cannabis production and distribution into a regulated, multibillion-dollar industry. However, a major issue for the industry is access to well-defined cannabis varieties, with supporting scientific information on their select traits.




Aequus Receives Approval for Short Form Base Shelf Prospectus to Raise up to C$20,000,000

Wed, 16 Aug 2017 14:29:42 EDT

VANCOUVER, BC--(Marketwired - August 16, 2017) -




Avadim Technologies Named to the Inc. 500 List of Fastest-Growing Private Companies in America for the Second Consecutive Year

Wed, 16 Aug 2017 13:42:42 EDT

Avadim Listed as the 13th Fastest Growing Company in U.S. Health Sector and 2nd Overall in North Carolina; Avadim Ranks No. 162 on the 2017 Inc. 500 List with Three-Year Sales Growth of 2,538%




Pressure BioSciences, Inc. Reports Second Quarter 2017 Financial Results and Provides Business Update

Wed, 16 Aug 2017 12:13:58 EDT

Total Revenue, Products & Services Revenue, Instrument Sales & Grant Activity All Increased Q/Q; New Five Person Field Sales Team Now Complete with Two Recent Additional Hires

Investor Conference Call Scheduled for Wednesday, August 16, 2017 at 4:30 PM EDT




Easton Pharmaceuticals Announces Advancing $575,000 Payment Towards Closed Agreement With Alliance Group For The Cultivation Of Medical / Recreational Marijuana For Canada and Other Revenue Producing Businesses

Wed, 16 Aug 2017 10:34:37 EDT

TORONTO, ON--(Marketwired - Aug 16, 2017) - Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), pursuant to its previously announced closing agreement with Canadian based -- Alliance Group -- Easton has advanced $575,000 towards its acquired interest in 45 acres of a 135-acre fully owned parcel of land for the cultivation, production and sale of medical / recreational marijuana to the cannabis industry and towards other revenue producing businesses.




MediXall Group, Inc. Provider Network Is Now Over 3,000 Members

Wed, 16 Aug 2017 10:08:23 EDT

MediXall Group is growing Provider Network -- preparing to offer a full suite of unique medical financing solutions to Network Members




Algae Dynamics Corp Enters Into a Letter of Intent With Bonify to Produce Unique Cannabis Oil Products; Accelerates Go-to-Market Strategy

Wed, 16 Aug 2017 09:30:00 EDT

TORONTO, ON--(Marketwired - Aug 16, 2017) - ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company"), a company focused on the development of unique health products and pharmaceuticals utilizing cannabis and algae oils, today announced that it has further refined its relationship with 6779264 Manitoba Ltd dba Bonify ("Bonify") in a Letter of Intent ("LOI") dated August 10, 2017. Bonify is a Licensed Producer, pursuant to the Access to Cannabis for Medical Purposes Regulations in Canada, with the capability to grow multiple strains of cannabis in its state-of-the-art 320,000 square foot facility.




Cannabis Science and Free Spirit Organics Native American Corporation (FSO NAC) Begin Harvesting Approximately 60 Acres of its 250-Acre Industrial Hemp Project on San Joaquin Sovereign Tribal Fee Land MBS, California

Wed, 16 Aug 2017 09:16:58 EDT

IRVINE, CA--(Marketwired - Aug 16, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, and Free Spirit Organics Native American Corporation (FSO NAC), announce the initial harvesting of approximately 60 acres of industrial hemp on San Joaquin Sovereign Tribal Fee land MBS, California. The 2017 CBIS/FSO NAC MBS001 harvesting is a two-phase project, the first phase of the harvesting will be approximately 15-acres that is underway now, it is expected to be completed by the end of this month. Phase two will be the remaining 45 acres and is expected to be completed by the end of September 2017.




First Harvest Launches Ufly420 for On-Demand Legal Cannabis Delivery

Wed, 16 Aug 2017 08:30:00 EDT

Enabling Connectivity Technology




Sipp Industries Signs Letter of Intent to Acquire Minority Stake in Wanderport Corporation, Enhancing Product Selection

Wed, 16 Aug 2017 08:30:00 EDT

Sipp Industries Diversifies Specialty Hemp Beverage Line with the Addition of Sapa's Premium Coffee Blends to its Portfolio of Top Quality Hemp Beverages




420JobSearch.com and ZipRecruiter.com Announce Partnership, Broadening Jobs Offered

Wed, 16 Aug 2017 08:00:00 EDT

HENDERSON, NV--(Marketwired - Aug 16, 2017) - mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis and vape markets with innovative products, technologies, and services is pleased to announce a partnership between its Job Search Portal (420JobSearch.com) and ZipRecruiter.com420jobsearch.com recently entered into an agreement with ziprecruiter.com to enable both companies to broaden the scope of jobs available to job seekers. 




LiveWire Ergogenics, Inc. Announces Analyst Coverage Initiated By Stock Watch Index

Wed, 16 Aug 2017 08:00:00 EDT

ANAHEIM, CA--(Marketwired - Aug 16, 2017) - LiveWire Ergogenics, Inc. (OTC PINK: LVVV), a company focused on research partnerships, product development and commercialization of cannabinoid-based products, is pleased to announce that Stock Watch Index has initiated equity analyst coverage on LVVV.




Tetra Bio-Pharma Announces Approval to List on the TSX Venture Exchange

Wed, 16 Aug 2017 08:00:00 EDT

OTTAWA, ONTARIO--(Marketwired - Aug. 16, 2017) - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(TSX VENTURE:TBP)(OTCQB:TBPMF), today announced that its common shares have been approved for trading on the TSX Venture Exchange and that it has applied for voluntary delisting of its common shares from the Canadian Securities Exchange (CSE). Tetra's shares will commence trading on the TSX Venture on the opening of markets on Wednesday, August 16, 2017, under the symbol "TBP".




NetworkNewsWire Announces Publication Discussing the Companies Ready to Strike on the Canadian Legal Marijuana Industry

Wed, 16 Aug 2017 07:30:00 EDT

NEW YORK, NY--(Marketwired - Aug 16, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ABcann Global (TSX VENTURE: ABCN) (OTCQB: ABCCF), a client of NNW that is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis.




Moleculin Acquires Active Drug Compound for the Treatment of Brain Cancer

Wed, 16 Aug 2017 07:30:00 EDT

HOUSTON, TX--(Marketwired - August 16, 2017) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the MD Anderson Cancer Center, today announced it has acquired WP1122 active drug compound it plans to study for the treatment of brain tumors.




Overcome Pharma Data Challenges to Improve Outcomes and Operations: Lessons Learned from Other Industries, New Webinar Hosted by Xtalks

Wed, 16 Aug 2017 07:30:00 EDT

TORONTO, ON--(Marketwired - August 16, 2017) - In a live session on Friday, September 8, 2017, industry expert Gary Palgon, Vice President of Healthcare and Life Sciences Solutions at Liaison Technologies will examine what the future holds for the healthcare and pharma ecosystems making the digital transformation, leveraging big data - including new and existing data sources - and using technologies to enhance clinical and operations processes.




Why Making Every Product Truly Unique is the Key to Modern Brand Protection

Wed, 16 Aug 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - August 16, 2017) - In this live webinar, Jim Sinisgalli, Director of Product Management and Brand Protection at Systech will outline their ability to create trusted uniqueness in every product, and how this idea is central to a modern approach to brand protection.




Solvents, Polymers & Cyclones -- Bioavailability Enhancement through Spray Dried Dispersions

Wed, 16 Aug 2017 07:00:00 EDT

TORONTO, ON--(Marketwired - August 16, 2017) - In an Xtalks webinar scheduled for Thursday, September 7, 2017 at 11am EDT (4pm BSK/UK), industry experts Stephie Lee, Associate Scientist at Catalent and Eric Gorman, Research Scientist II at Gilead Sciences, will introduce key spray dried dispersion development considerations allowing for identification of a stable prototype that will enhance and sustain in-vivo drug solubility. The discussion will include spray dried dispersion formulation development and early phase considerations for finished dose development.




Corix Bioscience, Inc. Signs Major Sales Agreement for up to 22,000 Pounds of Hemp per Month

Wed, 16 Aug 2017 06:00:00 EDT

PHOENIX, AZ--(Marketwired - Aug 16, 2017) - Corix Bioscience Inc. (OTCQB: CXBS), a next generation tissue cell culture to pharmaceutical grade cannabinoid oil (CBD) manufacturer, announced today that it has signed an agreement with Positively Green Organics LLC. for the resale of up to 22,000 pounds of industrial hemp per month.




Zecotek Receives LFS Scintillation Crystal Order for NeuroPET Brain Scanning Device

Wed, 16 Aug 2017 03:15:00 EDT

SINGAPORE--(Marketwired - August 16, 2017) - Zecotek Photonics Inc. (TSX VENTURE: ZMS) (FRANKFURT: W1I) (OTC PINK: ZMSPF), developer of leading-edge photonics technologies for healthcare, industrial and scientific markets, is pleased to announce that it has received an order for its patented Lutetium Fine Silicate (LFS) scintillation crystals from a medical imaging device manufacturer based in the United States for use in a newly developed neuroPET scanner. Positron emission tomography (PET) medical scanning has been successful at identifying functional abnormalities with brain tissues. New and more specialized PET imaging devices are being developed to provide greater functional information in the detection of tumors and diseased tissue, measurement of cellular and tissue metabolism, blood flow, and the evaluation of patients who have seizures, memory disorders such as Alzheimer and Parkinson, and mood abnormalities.




Hemostemix Announces Updates on Private Placement

Tue, 15 Aug 2017 21:26:30 EDT

BLACKFALDS, ALBERTA--(Marketwired - Aug. 15, 2017) -




Hemostemix Announces Updates on Rights Offering

Tue, 15 Aug 2017 21:24:16 EDT

BLACKFALDS, ALBERTA--(Marketwired - Aug. 15, 2017) -




Dynavax Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock

Tue, 15 Aug 2017 16:01:00 EDT

BERKELEY, CA--(Marketwired - August 15, 2017) - Dynavax Technologies Corporation (NASDAQ: DVAX) today announced the completion of an underwritten public offering of 5,750,000 shares of its common stock, including 750,000 shares sold pursuant to the full exercise of an over-allotment option previously granted to the underwriters. All of the shares were offered by Dynavax at a price to the public of $15.00 per share. The net proceeds to Dynavax from this offering were approximately $80.8 million, after deducting the underwriting discount and other estimated offering expenses payable by Dynavax. Dynavax anticipates using the net proceeds from the proposed offering to fund activities associated with preparing for the anticipated U.S. commercial launch of HEPLISAV-BT [Hepatitis B Vaccine (Recombinant), Adjuvanted], should HEPLISAV-B gain approval by the Food and Drug Administration. In addition, net proceeds from the offering will support continuing the clinical development of its lead investigational cancer immunotherapeutic product candidates, SD-101 and DV281, continuing research and development activities, and for other general corporate purposes, including working capital.




Reflect Scientific Adds Patent Expertise to Advisory Board

Tue, 15 Aug 2017 10:35:36 EDT

OREM, UT--(Marketwired - August 15, 2017) - Reflect Scientific, Inc. (OTC: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries announced the addition of Mr. Bao Tran to the advisory board.

Mr. Tran is the principal at Tran & Associates, a patent boutique firm. Bao has been a patent attorney since 1987 with over 30 years of experience in management consulting and intellectual property portfolio design and build-out. His accomplishments include founding PowerPatent, Inc., a patent portfolio development software system, and building patent portfolios for companies such as Shutterfly, NEC Research, among others. At Align Technology (NASDAQ: ALGN), he architected the Invisalign® patent portfolio. With an abundance of US and international legal affair and management consulting experience, Mr. Tran is uniquely positioned to help Reflect leverage its intellectual property.